Elder Pharma Forays Into the Nasal Inhaler Segment With the Launch of ‘Solo’ Inhalers

With a firm footing in the health and well-being segment, Elder Pharmaceuticals Limited (NSE: ELDERPHARM) has expanded its Solo range of OTC products with the launch of Solo range of inhalers for nasal congestion. The Solo basket comprises of Solo Rub, a pain balm, Solo Cough Drops and Solo lozenges for throat soothening. With an eye on the rural markets, the company is also launching these products in smaller sizes and has earmarked a budget of Rs. 25 crore for promotional activities.

Elder foresees an 8-10% annual growth in the nasal decongestion market and is banking on substantial growth from category B and C towns. The market is presently valued at Rs. 800 crore with Vicks from P&G dominating with more than 50% market share. Market for inhalation generic drugs is quite promising for India due to climate change and rapidly aging demographics where 22% of population is above 55 years of age. Although the market leaders are everywhere, there is still a large untapped market in India and Elder is hoping to garner a 7% share of the nasal decongestant market by FY2018.

Alok Saxena, Managing Director, Elder Pharmaceuticals Limited, says, “Over-the-counter inhalers are the first level treatment for nasal congestion and doctors/specialists are consulted only if the condition worsens. Rising cost of raw materials, competitive market conditions and over dependency on the urban markets had affected the sales of the company’s OTC products in the recent years. With focus on price, product mix and penetration, Elder is set to regain its prime position in the OTC sector.”

The market for cough and cold care solutions too witnessed a growth of 10% during 2013-14 due to increasingly erratic weather, whereby the temperature kept switching from hot and humid to cold and rainy, further increasing seasonal health problems such as cough, cold and allergies. It is for this reason that the company has also introduced Solo lozenges in polypack for better visibility and customer use. An ayurvedic cough syrup, which gives more than 12 hours of relief and has no side effects, is also ready for launch in April 2015.

India’s Fast Moving Health Goods (FMHG) sector has shown higher growth of 18% in rural areas as compared to 11% in urban areas. Although urban areas have high spending propensity, there has been a rise in disposable incomes levels in the rural economy and consequently in demand for FMHG products.

Saxena adds, “In view of the highly competitive nature of the industries we operate in, we plan to focus on branding, packaging upgrades, wider distribution and innovation to make our brands successful. The company has also lined up marketing strategies to offer combination products for an attractive price in order to lure the rural consumers to try out it new launches.”



New Round of Extreme Cold Puts Elderly at Risk

File:Snow branch ice.jpgWith a new, extreme round of cold weather upon us today and for the next few days, it’s critical to wear layers, stay warm, protect yourself against falls and injuries, and check in on elderly relatives, friends, and neighbors who may be at particular risk of cold-related health problems. Simple, quick steps can help you and others stay warm and safe in the current, life-threatening freeze.

Here’s what you need to know to stay safe:

  • Protect your skin. At temperatures of 15 to 30 below, exposed skin can get frostbitten in minutes. For older adults with reduced blood circulation or those improperly dressed, the risk is even higher.
  • Try not to stay outside more than 20 minutes. Wear a hat that comes down over your ears, protect your face and neck. Mittens are better than gloves, layers are best.
  • If you think you may have suffered frostbite, do not thaw using hot water or a heating pad. Use lukewarm water or your own body heat to thaw.  Seek medical attention.
  • Wear layers the right way. If you must go outside, wear layers to protect against heat loss and wetness. And don’t forget your hat.
  • Make sure your home is warm enough. Frigid weather can pose special risks to older people. Set the thermostat to at least 68 to 70 degrees. Make sure feet are kept warm
  • Protect against falls and injuries. With temperatures this low, the salt normally used to melt ice and snow on roads and sidewalks doesn’t work as well.
  • Warn your kids and grandkids. Younger folks, who may not understand the risks of these record temperatures, also need to be encouraged to take the necessary precautions.
  • Check on elderly neighbors or relatives to be sure they’re warm and safe. Don’t allow pets to stay outside except for short periods.

Study: RSV Often Milder than Flu in Older Adults

Respiratory Syncytial Virus (RSV) appears to cause milder illness than influenza in adults age 50 or older, according to researchers at Marshfield Clinic Research Foundation.

The study, published online in Clinical Infectious Diseases, also shows that Respiratory Syncytial Virus is a common cause of respiratory illness in older adults and that the chance of infection with RSV increases with age.

“RSV has long been known to cause serious respiratory illness in infants, but much less is known about the illnesses RSV causes in older adults,” said Dr. Edward Belongia, director of the Epidemiology Research Center at Marshfield Clinic Research Foundation (MCRF). “Knowing that adults’ susceptibility to RSV increases as they age is important for health care providers and public health officials to note as they treat and monitor respiratory illnesses this season.”

RSV is a common virus that causes infections of the lungs and breathing passages. The virus is thought to cause about 10 percent of winter hospitalizations for pneumonia in adults 65 and older. Most healthy people recover from RSV in one to two weeks, but for some infants, children and older adults, RSV causes serious illness. Most children have had RSV by age 2.

Study results suggest flu may cause more severe illness than RSV in older adults. That’s based on two key points:

  • People with RSV delayed seeking treatment after the onset of illness more than patients with flu.
  • Fewer RSV patients were hospitalized within 30 days compared to those with flu.

Symptoms of RSV are cold-like in most instances and include congested or runny nose, dry cough, low-grade fever, sore throat and headache. In severe cases, the contagious virus causes high fever, severe cough, wheezing, rapid breathing and bluish color of the skin due to lack of oxygen.

“Influenza gets a lot of attention this time of the year and for good reason – it’s a serious illness that affects thousands of people,” said MCRF epidemiologist Maria Sundaram, one of the study’s lead authors. “Although this study showed RSV may lead to fewer complications than flu, it still has the potential to cause serious respiratory illness, especially in older adults with weakened immune systems or other pre-existing conditions.”

Further work is needed to understand why older adults are more susceptible to RSV than other groups, MCRF researchers said. For the study, scientists including Dr. Jennifer Meece, director of MCRF’s Core Laboratory, studied nasal and throat swabs from patients age 50 and older recruited for influenza vaccine effectiveness studies from 2004-10. MedImmune, LLC, provided funding for this study.